Global Spatiotemporal Disease Surveillance System
Abstract
We have developed and commercialized a @Clinic reader and a @Home reader hardware and software, PC-based Test Developer Software and Test Explorer Software and HIPAA compliant cloud architecture, finalized a preliminary clinical study and completed the documentation. The platform has been so far sold to 30+ customers in 5+ countries in the world, receiving significant interest from the immunoassay manufacturers, researchers and academics. Throughout the project, we constantly monitored the market and collected very useful feedback from our partners, customers and prospects to address the evolving requirements of the market and lead the competition in the reader business. We have been able to adapt the originally set goals and further enhance the expected results. Our platform now offers a unique all-in-one solution for immunoassay analysis. It costs half the price or less than other reader technologies while achieving comparable or better sensitivity and accuracy.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 12, 2017
- Accession Number
- AD1086065
Entities
People
- Onur Mudanyali